Background: Office-based rhinologic procedures are increasingly performed to control costs and enhance patient convenience. Adequate management of pain and anxiety is essential for the technical performance of these procedures, in addition to ensuring patient comfort. Pharmacologic agents are often used to manage anxiety and pain. Nonpharmacological adjuncts may be useful for achieving these effects without oral opioids and benzodiazepines. Methods: Charts of patients who underwent office-based rhinologic procedures with the NuCalm system (Solace Lifesciences, Inc., Wilmonton, DE, USA) in combination with local anesthesia were reviewed. NuCalm is a proprietary system that combines cranial electrotherapy stimulation, neuroacoustic software, light-blocking lenses, and topical γ--aminobutyric acid. Patients rated their pain and anxiety before, during, and after the procedure. Results: Twenty-five patients underwent office procedures using the NuCalm system. Preoperative anxiety (2.00) was significantly higher than postoperative anxiety (1.25) according to patient reporting on a 5-point scale (p = 0.005). Preoperative pain (1.83) was not significantly different from intraoperative (2.54) and postoperative pain (2.04, p = 0.054). Conclusions: A variety of office-based rhinologic procedures are technically feasible and can be performed with adequate patient comfort without the use of oral drugs. Adjuncts to pharmacologic agents may enhance pain control and anxiety management and improve patient tolerance of these procedures.

1.
Thamboo
A
,
Patel
ZM
.
Office procedures in refractory chronic rhinosinusitis
.
Otolaryngol Clin North Am
.
2017
Feb
;
50
(
1
):
113
28
.
[PubMed]
0030-6665
2.
Varshney
R
,
Lee
JT
.
New innovations in office-based rhinology
.
Curr Opin Otolaryngol Head Neck Surg
.
2016
Feb
;
24
(
1
):
3
9
.
[PubMed]
1068-9508
3.
Prickett
KK
,
Wise
SK
,
DelGaudio
JM
.
Cost analysis of office-based and operating room procedures in rhinology
.
Int Forum Allergy Rhinol
.
2012
May-Jun
;
2
(
3
):
207
11
.
[PubMed]
2042-6976
4.
Benninger
MS
,
Sindwani
R
,
Holy
CE
,
Hopkins
C
.
Early versus delayed endoscopic sinus surgery in patients with chronic rhinosinusitis: impact on health care utilization
.
Otolaryngol Head Neck Surg
.
2015
Mar
;
152
(
3
):
546
52
.
[PubMed]
0194-5998
5.
Hopkins
C
,
Rimmer
J
,
Lund
VJ
.
Does time to endoscopic sinus surgery impact outcomes in Chronic Rhinosinusitis? Prospective findings from the National Comparative Audit of Surgery for Nasal Polyposis and Chronic Rhinosinusitis
.
Rhinology
.
2015
Mar
;
53
(
1
):
10
7
.
[PubMed]
0300-0729
6.
Hopkins
C
,
Andrews
P
,
Holy
CE
.
Does time to endoscopic sinus surgery impact outcomes in chronic rhinosinusitis? Retrospective analysis using the UK clinical practice research data
.
Rhinology
.
2015
Mar
;
53
(
1
):
18
24
.
[PubMed]
0300-0729
7.
Smith
KA
,
Orlandi
RR
,
Rudmik
L
.
Cost of adult chronic rhinosinusitis: A systematic review
.
Laryngoscope
.
2015
Jul
;
125
(
7
):
1547
56
.
[PubMed]
0023-852X
8.
Roh
HT
,
So
WY
.
Cranial electrotherapy stimulation affects mood state but not levels of peripheral neurotrophic factors or hypothalamic-pituitary-adrenal axis regulation
.
Technol Health Care
.
2016
; [
epub ahead of print
].
[PubMed]
0928-7329
9.
Kirsch
DL
,
Price
LR
,
Nichols
F
,
Marksberry
JA
,
Platoni
KT
.
Military service member and veteran self reports of efficacy of cranial electrotherapy stimulation for anxiety, posttraumatic stress disorder, insomnia, and depression
.
US Army Med Dep J
.
2014
Oct-Dec
;(
Oct-Dec
):
46
54
.
[PubMed]
1524-0436
10.
Barclay
TH
,
Barclay
RD
.
A clinical trial of cranial electrotherapy stimulation for anxiety and comorbid depression
.
J Affect Disord
.
2014
Aug
;
164
:
171
7
.
[PubMed]
0165-0327
11.
Lee
SH
,
Kim
WY
,
Lee
CH
,
Min
TJ
,
Lee
YS
,
Kim
JH
, et al.
Effects of cranial electrotherapy stimulation on preoperative anxiety, pain and endocrine response
.
J Int Med Res
.
2013
Dec
;
41
(
6
):
1788
95
.
[PubMed]
0300-0605
12.
Bystritsky
A
,
Kerwin
L
,
Feusner
J
.
A pilot study of cranial electrotherapy stimulation for generalized anxiety disorder
.
J Clin Psychiatry
.
2008
Mar
;
69
(
3
):
412
7
.
[PubMed]
0160-6689
13.
Tan
G
,
Rintala
DH
,
Jensen
MP
,
Richards
JS
,
Holmes
SA
,
Parachuri
R
, et al.
Efficacy of cranial electrotherapy stimulation for neuropathic pain following spinal cord injury: a multi-site randomized controlled trial with a secondary 6-month open-label phase
.
J Spinal Cord Med
.
2011
;
34
(
3
):
285
96
.
[PubMed]
1079-0268
14.
Winick
RL
.
Cranial electrotherapy stimulation (CES): a safe and effective low cost means of anxiety control in a dental practice
.
Gen Dent
.
1999
Jan-Feb
;
47
(
1
):
50
5
.
[PubMed]
0363-6771
15.
Feusner
JD
,
Madsen
S
,
Moody
TD
,
Bohon
C
,
Hembacher
E
,
Bookheimer
SY
, et al.
Effects of cranial electrotherapy stimulation on resting state brain activity
.
Brain Behav
.
2012
May
;
2
(
3
):
211
20
.
[PubMed]
2162-3279
16.
Holloway
GB
;
Solace Life Sciences.
Nucalm technical file. Published January
2015
.
17.
Centers for Disease Control and Prevention (CDC)
.
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999–2008
.
MMWR Morb Mortal Wkly Rep
.
2011
Nov
;
60
(
43
):
1487
92
.
[PubMed]
1545-861X
18.
Rudd
RA
,
Seth
P
,
David
F
,
Scholl
L
.
Increase in drug and opioid-involved overdose deaths – United States, 2010-2015
.
MMWR Morb Mortal Wkly Rep
.
2016
Dec
;
65
(
50-51
):
1445
52
.
[PubMed]
0149-2195
19.
Trotter Davis
M
,
Bateman
B
,
Avorn
J
.
Education outreach to opioid prescribers: the case for academic detailing
.
Pain Physician
.
2017
Feb
;
20
2S
:
S147
51
.
[PubMed]
2150-1149
20.
Hsu
ES
.
Medication overuse in chronic pain
.
Curr Pain Headache Rep
.
2017
Jan
;
21
(
1
):
2
.
[PubMed]
1531-3433
21.
Harris
PA
,
Taylor
R
,
Thielke
R
,
Payne
J
,
Gonzalez
N
,
Conde
JG
.
Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support
.
J Biomed Inform
.
2009
Apr
;
42
(
2
):
377
81
.
[PubMed]
1532-0464
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.